Kidney-Related Outcome in Cardiorenal Syndrome Type 3

Table 4

Distribution of all variables in subjects without versus with incomplete or complete recovery of kidney function.

Variable	No recovery	Incomplete recovery	Complete recovery	value
Gender (females in %)	44.2	44.4	44.2	1
Age (mean years+/−SD)	79.9+/−1.3	84.3+/−2.3	78+/−2	0.35
In-hospital stay (means days+/−SD)	18.8+/−2.4	18.3+/−1.9	25.3+/−3.1	0.037
AKIN stage (1/2/3 in %)	23.1/48.1/28.8	33.3/22.2/44.4	11.8/32.4/55.9	0.09
Initial serum creatinine (micro-Mol/L+/−SD)	194.5+/−16.6	162.1+/−13.1	305+/−36.1	0.011
Peak serum creatinine (micro-Mol/L+/−SD)	337.2+/−19.2	313.7+/−30.9	372.2+/−33.1	0.75
Serum creatinine before discharge (micro-Mol/L+/−SD)	280.3+/−20.6	158.3+/−12.9	140.8+/−16.4	<0.001
Initial serum sodium (mMol/L+/−SD)	139.1+/−0.8	138.6+/−1.5	135.1+/−1.2	0.029
Minimal serum sodium (mMol/L+/−SD)	136.1+/−0.86	136+/−1.1	133.3+/−1	0.12
Peak serum sodium (mMol/L+/−SD)	143.4+/−0.8	144.1+/−0.92	145+/−0.87	0.22
Initial serum potassium (mMol/L+/−SD)	4.8+/−0.8	5.1+/−0.12	5+/−0.2	0.56
Minimal serum potassium (mMol/L+/−SD)	3.9+/−0.11	3.6+/−0.17	3.5+/−0.1	0.031
Peak serum potassium (mMol/L+/−SD)	5.2+/−0.1	5.2+/−0.15	5.38+/−0.14	0.61
Initial NT-proBNP (pg/mL)	10,319+/−1,770	13,615+/−3,697	9,501+/−2,616	0.41
Peak NT-proBNP (pg/mL)	12,822+/−1,859	17,263+/−3,967	10,181+/−1,955	0.18
Initial CRP (mg/L+/−SD)	40.5+/−6.4	78+/−23.1	61.2+/−15.2	0.43
Peak CRP (mg/L+/−SD)	124.2+/−13.5	154.6+/−27	143.9+/−20.9	0.45
Vasopressors (%)	9.6	0	8.8	0.62
Invasive ventilation (%)	17.3	0	8.8	0.4
Arterial hypertension (%)	92.3	100	88.2	0.51
Diabetes (%)	67.3	33.3	47.1	0.06
Obesity (%)	58.8	22.2	58.8	0.11
Preexisting CHF (%)	23.1	44.4	29.4	0.39
Preexisting CAD (%)	38.5	33.3	47.1	0.64
COPD (%)	21.1	33.3	11.8	0.24
Hyperuricemia (%)	21.2	22.2	29.4	0.67
History of cancer (%)	28.8	11.1	29.4	0.51